NCT02434887

Brief Summary

The purpose of this study is to verify the effectiveness of the investigational product through Subjective Assessment and answered by volunteers.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2015

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 15, 2015

Completed
21 days until next milestone

First Posted

Study publicly available on registry

May 6, 2015

Completed
26 days until next milestone

Study Start

First participant enrolled

June 1, 2015

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2015

Completed
Last Updated

November 10, 2015

Status Verified

November 1, 2015

Enrollment Period

Same day

First QC Date

April 15, 2015

Last Update Submit

November 9, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Evaluation of the product's efficiency as a moisturizer through subjective evaluation

    40 days

Study Arms (1)

Experimental group

EXPERIMENTAL
Device: KL029 Intimate Lubricant Gel

Interventions

Experimental group

Eligibility Criteria

Age45 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female aged between 45 to 65 years old
  • Sexually active volunteers, with a minimum of 1 intercourse per week
  • In menopause for at least 6 months;
  • Intact skin in the product analysis region;
  • No prior reactions to topical products
  • Reading, understanding, agreement and signature of the informed consent form

You may not qualify if:

  • Use of anti-inflammatory and immunosuppressive ( in the last 30 days and during the study)
  • Active skin diseases (local or disseminated) in the evaluation área;
  • Diseases that cause imune suppression;
  • Endocrine disorders such as thyroid, ovarian or adrenal gland disorders;
  • Any infection in the region where the product will be analyzed diagnosed at enrollment;
  • Other conditions considered by the investigator physician as reasonable for the disqualification of the individual's participation in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
SINGLE
Who Masked
PARTICIPANT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 15, 2015

First Posted

May 6, 2015

Study Start

June 1, 2015

Primary Completion

June 1, 2015

Study Completion

August 1, 2015

Last Updated

November 10, 2015

Record last verified: 2015-11